Literature DB >> 9398945

Chemical speciation of arsenic in urine of patients with blackfoot disease.

T H Lin1, Y L Huang.   

Abstract

Blackfoot disease is a peripheral vascular disease resulting in gangrene of the lower extremities. Although extensive epidemiological study has implicated high arsenic content in artesian well water of the endemic area bears some important connection with the disease, the etiology of the disease is still not clarified. In this study, attention is paid to chemical speciation of arsenic in order to find out whether the concentrations of arsenic species in urine of Blackfoot disease patients are different from those of controls. Experimental results indicate that the total arsenic, inorganic arsenic, monomethylarsonic acid, and other forms of arsenic in the urine of patients are significantly higher than those of the controls. The possible connection of those arsenic species with the etiology of the disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9398945     DOI: 10.1007/bf02789407

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  22 in total

1.  Use of human metabolic studies and urinary arsenic speciation in assessing arsenic exposure.

Authors:  L R Johnson; J G Farmer
Journal:  Bull Environ Contam Toxicol       Date:  1991-01       Impact factor: 2.151

2.  [Physico-chemical characteristics of drinking water in blackfoot endemic areas in Chia-I and Tainan Hsiens].

Authors:  F J Lu; C K Yang; K H Ling
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1975-09

3.  [Studies on fluorescent compound in drinking water of blackfoot disease endemic areas. (1) Toxic effects of the fluorescent compound on chick embryos].

Authors:  F J Lu; M H Tsai; K H Ling
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1977-01

4.  Skin cancer in chronic arsenicism.

Authors:  S Yeh
Journal:  Hum Pathol       Date:  1973-12       Impact factor: 3.466

5.  [Studies on fluorescent compounds in drinking water of blackfoot disease endemic areas. 6. A preliminary experimental study on peripheral vasculopathy (author's transl)].

Authors:  F J Lu; K H Ling
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1979-04

6.  Metabolism and excretion of orally ingested trimethylarsenic in man.

Authors:  H Yamauchi; Y Yamamura
Journal:  Bull Environ Contam Toxicol       Date:  1984-06       Impact factor: 2.151

7.  Tissue distribution and retention of 74As-dimethylarsinic acid in mice and rats.

Authors:  M Vahter; E Marafante; L Dencker
Journal:  Arch Environ Contam Toxicol       Date:  1984-05       Impact factor: 2.804

8.  Separation of arsenic metabolites in dog plasma and urine following intravenous injection of 74As.

Authors:  K H Tam; S M Charbonneau; F Bryce; G Lacroix
Journal:  Anal Biochem       Date:  1978-06-01       Impact factor: 3.365

9.  Arsenic concentration in the urine of patients with Blackfoot disease and Bowen's disease.

Authors:  S M Lin; C H Chiang; M H Yang
Journal:  Biol Trace Elem Res       Date:  1985-08       Impact factor: 3.738

10.  Biological monitoring of arsenic exposure of gallium arsenide- and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair.

Authors:  H Yamauchi; K Takahashi; M Mashiko; Y Yamamura
Journal:  Am Ind Hyg Assoc J       Date:  1989-11
View more
  3 in total

1.  Urinary arsenic metabolites of subjects exposed to elevated arsenic present in coal in Shaanxi Province, China.

Authors:  Jianwei Gao; Jiangping Yu; Linsheng Yang
Journal:  Int J Environ Res Public Health       Date:  2011-06-03       Impact factor: 3.390

2.  Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine.

Authors:  X C Le; M Ma; W R Cullen; H V Aposhian; X Lu; B Zheng
Journal:  Environ Health Perspect       Date:  2000-11       Impact factor: 9.031

3.  Association between lifetime exposure to inorganic arsenic in drinking water and coronary heart disease in Colorado residents.

Authors:  Katherine A James; Tim Byers; John E Hokanson; Jaymie R Meliker; Gary O Zerbe; Julie A Marshall
Journal:  Environ Health Perspect       Date:  2014-10-28       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.